2020
DOI: 10.1111/adb.12995
|View full text |Cite
|
Sign up to set email alerts
|

Regulation of GluA1 phosphorylation by d‐amphetamine and methylphenidate in the cerebellum

Abstract: Prescription stimulants, such as d-amphetamine or methylphenidate are used to treat suffering from attention-deficit hyperactivity disorder (ADHD). They potently release dopamine (DA) and norepinephrine (NE) and cause phosphorylation of the α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor subunit GluA1 in the striatum. Whether other brain regions are also affected remains elusive. Here, we demonstrate that d-amphetamine and methylphenidate increase phosphorylation at Ser845 (pS845-GluA1) in… Show more

Help me understand this report
View preprint versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
0
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
3

Relationship

1
2

Authors

Journals

citations
Cited by 3 publications
(1 citation statement)
references
References 62 publications
0
0
0
Order By: Relevance
“…Analyses of Drd2, Pvalb, Penk, Chat and Slc18a3 mRNAs expression were performed using single molecule fluorescent in situ hybridization (smFISH) (28). Brains from 3 C57BL/6 male mice were rapidly extracted and snap-frozen on dry ice and stored at -80°C until use.…”
Section: Single Molecule Fluorescent In Situ Hybridizationmentioning
confidence: 99%
“…Analyses of Drd2, Pvalb, Penk, Chat and Slc18a3 mRNAs expression were performed using single molecule fluorescent in situ hybridization (smFISH) (28). Brains from 3 C57BL/6 male mice were rapidly extracted and snap-frozen on dry ice and stored at -80°C until use.…”
Section: Single Molecule Fluorescent In Situ Hybridizationmentioning
confidence: 99%